✦ LIBER ✦

UK Expanded Access Programme (EAP): Herceptin® (trastuzumab) treatment for women with HER2 positive Metastatic Breast Cancer (MBC)

✍ Scribed by D. Miles; A. Wroath

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A cost-effectiveness analysis of Hercept

✍ A. Ratcliffe; C. Poole; D. Miles 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Phase II study of weekly docetaxel (Taxo

✍ F.J. Esteva; V. Valero; D. Booser; L.T. Guerra; J.L. Murray; L. Pusztai; M. Cris 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Central nervous system metastases in wom

✍ Sarah-Jane DAWSON; Nadia F RANIERI; Raymond D SNYDER; Sue-Anne McLACHLAN; Willia 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Trastuzumab (Herceptin®) plus docetaxel

✍ J.M Extra; F Cognetti; D Maranichi; R Snyder; L Mauriac; M Tubiana-Hulin; S Chan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 348 KB

Health-related quality of life (HRQL) in

✍ D. Osoba; D. Slamon; M. Burchmore; M. Murphy 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Treatment of HER2-positive metastatic br

✍ Sutherland, S; Ashley, S; Miles, D; Chan, S; Wardley, A; Davidson, N; Bhatti, R; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 450 KB